FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040273337> ?p ?o ?g. }

• W2040273337 endingPage "653" @default.
• W2040273337 startingPage "646" @default.
• W2040273337 abstract "Background Combination cytotoxic agents in breast cancer carry dose-limiting toxicities. The aim of this study was to test the hypothesis that nanocarrier-conjugated doxorubicin and cisplatin would have improved tumor efficacy with decreased systemic toxicity over standard drugs, even at lower doses. Methods Female Nu/Nu mice were injected in the breast with human MDA-MB-468LN cells and treated with either standard or nanocarrier-conjugated combination therapy (doxorubicin plus cisplatin) at 50% or 75% maximum tolerated dose (MTD) and monitored for efficacy and toxicity over 12 weeks. Results Efficacy results for mice treated with hyaluronan-conjugated doxorubicin and cisplatin at 50% MTD were as follows: 5 complete responses, 2 partial responses, and 1 case of stable disease. For hyaluronan-conjugated doxorubicin and cisplatin at 75% MTD, efficacy results were as follows: 7 complete responses, 1 partial response. All complete responses were confirmed histologically. In comparison, mice given standard doxorubicin and cisplatin at 50% MTD demonstrated progressive disease in 6, stable disease in 1, and partial response in 1. For standard doxorubicin and cisplatin at 75% MTD, there were 5 cases of progressive disease and 3 of stable disease (P < .0001 on multivariate analysis of variance). At 75% MTD, standard drug–treated mice had significant weight loss compared to nanocarrier drug–treated mice (P < .001). Conclusions Subcutaneous nanocarrier delivery of doxorubicin and cisplatin demonstrated significantly improved efficacy with decreased toxicity compared with standard agent combination therapy at all doses tested, achieving complete pathologic tumor response." @default.
• W2040273337 created "2016-06-24" @default.
• W2040273337 creator A5000215441 @default.
• W2040273337 creator A5014639852 @default.
• W2040273337 creator A5046407367 @default.
• W2040273337 creator A5051722819 @default.
• W2040273337 creator A5057675169 @default.
• W2040273337 creator A5058554865 @default.
• W2040273337 date "2011-12-01" @default.
• W2040273337 modified "2023-09-27" @default.
• W2040273337 title "Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo" @default.
• W2040273337 cites W1888411879 @default.
• W2040273337 cites W1913795200 @default.
• W2040273337 cites W1987593270 @default.
• W2040273337 cites W2006198477 @default.
• W2040273337 cites W2019119894 @default.
• W2040273337 cites W2023209653 @default.
• W2040273337 cites W2033117404 @default.
• W2040273337 cites W2036067444 @default.
• W2040273337 cites W2036443620 @default.
• W2040273337 cites W2067061342 @default.
• W2040273337 cites W2091574730 @default.
• W2040273337 cites W2114764091 @default.
• W2040273337 cites W2148507283 @default.
• W2040273337 cites W2158734599 @default.
• W2040273337 cites W2159081661 @default.
• W2040273337 cites W2164122108 @default.
• W2040273337 cites W2168015221 @default.
• W2040273337 cites W2169432501 @default.
• W2040273337 cites W2313365551 @default.
• W2040273337 doi "https://doi.org/10.1016/j.amjsurg.2011.06.027" @default.
• W2040273337 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5198781" @default.
• W2040273337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21982998" @default.
• W2040273337 hasPublicationYear "2011" @default.
• W2040273337 type Work @default.
• W2040273337 sameAs 2040273337 @default.
• W2040273337 citedByCount "38" @default.
• W2040273337 countsByYear W20402733372012 @default.
• W2040273337 countsByYear W20402733372013 @default.
• W2040273337 countsByYear W20402733372014 @default.
• W2040273337 countsByYear W20402733372015 @default.
• W2040273337 countsByYear W20402733372016 @default.
• W2040273337 countsByYear W20402733372017 @default.
• W2040273337 countsByYear W20402733372018 @default.
• W2040273337 countsByYear W20402733372019 @default.
• W2040273337 countsByYear W20402733372020 @default.
• W2040273337 countsByYear W20402733372021 @default.
• W2040273337 countsByYear W20402733372022 @default.
• W2040273337 countsByYear W20402733372023 @default.
• W2040273337 crossrefType "journal-article" @default.
• W2040273337 hasAuthorship W2040273337A5000215441 @default.
• W2040273337 hasAuthorship W2040273337A5014639852 @default.
• W2040273337 hasAuthorship W2040273337A5046407367 @default.
• W2040273337 hasAuthorship W2040273337A5051722819 @default.
• W2040273337 hasAuthorship W2040273337A5057675169 @default.
• W2040273337 hasAuthorship W2040273337A5058554865 @default.
• W2040273337 hasBestOaLocation W20402733372 @default.
• W2040273337 hasConcept C121608353 @default.
• W2040273337 hasConcept C126322002 @default.
• W2040273337 hasConcept C150903083 @default.
• W2040273337 hasConcept C18150654 @default.
• W2040273337 hasConcept C207001950 @default.
• W2040273337 hasConcept C2776694085 @default.
• W2040273337 hasConcept C2776999253 @default.
• W2040273337 hasConcept C2778239845 @default.
• W2040273337 hasConcept C2780035454 @default.
• W2040273337 hasConcept C2781303535 @default.
• W2040273337 hasConcept C29730261 @default.
• W2040273337 hasConcept C530470458 @default.
• W2040273337 hasConcept C71924100 @default.
• W2040273337 hasConcept C86803240 @default.
• W2040273337 hasConcept C98274493 @default.
• W2040273337 hasConceptScore W2040273337C121608353 @default.
• W2040273337 hasConceptScore W2040273337C126322002 @default.
• W2040273337 hasConceptScore W2040273337C150903083 @default.
• W2040273337 hasConceptScore W2040273337C18150654 @default.
• W2040273337 hasConceptScore W2040273337C207001950 @default.
• W2040273337 hasConceptScore W2040273337C2776694085 @default.
• W2040273337 hasConceptScore W2040273337C2776999253 @default.
• W2040273337 hasConceptScore W2040273337C2778239845 @default.
• W2040273337 hasConceptScore W2040273337C2780035454 @default.
• W2040273337 hasConceptScore W2040273337C2781303535 @default.
• W2040273337 hasConceptScore W2040273337C29730261 @default.
• W2040273337 hasConceptScore W2040273337C530470458 @default.
• W2040273337 hasConceptScore W2040273337C71924100 @default.
• W2040273337 hasConceptScore W2040273337C86803240 @default.
• W2040273337 hasConceptScore W2040273337C98274493 @default.
• W2040273337 hasIssue "6" @default.
• W2040273337 hasLocation W20402733371 @default.
• W2040273337 hasLocation W20402733372 @default.
• W2040273337 hasLocation W20402733373 @default.
• W2040273337 hasLocation W20402733374 @default.
• W2040273337 hasLocation W20402733375 @default.
• W2040273337 hasOpenAccess W2040273337 @default.
• W2040273337 hasPrimaryLocation W20402733371 @default.
• W2040273337 hasRelatedWork W2028614512 @default.
• W2040273337 hasRelatedWork W2048746306 @default.
• W2040273337 hasRelatedWork W2052185098 @default.

• next